Chapter 1. LAMEA Market
1.1 Market Overview
1.2 Key Factors Impacting Market
1.2.1 Market Drivers
1.2.2 Market Restraints
1.2.3 Market Opportunities
1.2.4 Market Challenges
1.2.5 Market Trends
1.2.6 State of Competition
1.2.7 Market Consolidation
1.2.8 Key Customer Criteria
1.3 Product Life Cycle
1.4 Segmentation By Service
1.4.1 Screening
1.4.2 Diagnostic
1.4.3 Interventional
1.5 Segmentation By Imaging Modality
1.5.1 D Digital
1.5.2 D Digital Breast Tomosynthesis
1.5.3 Contrast-Enhanced
1.5.4 Other Imaging Modality
1.6 Segmentation By End-User
1.6.1 Hospitals
1.6.2 Specialty Clinics
1.6.3 Diagnostic Centers
1.6.4 Other End-User
1.7 Segmentation By Country
1.7.1 Brazil
1.7.1.1 Segmentation By Service
1.7.1.1.1 Screening
1.7.1.1.2 Diagnostic
1.7.1.1.3 Interventional
1.7.1.2 Segmentation By Imaging Modality
1.7.1.2.1 D Digital
1.7.1.2.2 D Digital Breast Tomosynthesis
1.7.1.2.3 Contrast-Enhanced
1.7.1.2.4 Other Imaging Modality
1.7.1.3 Segmentation By End-User
1.7.1.3.1 Hospitals
1.7.1.3.2 Specialty Clinics
1.7.1.3.3 Diagnostic Centers
1.7.1.3.4 Other End-User
1.7.2 Argentina
1.7.2.1 Segmentation By Service
1.7.2.1.1 Screening
1.7.2.1.2 Diagnostic
1.7.2.1.3 Interventional
1.7.2.2 Segmentation By Imaging Modality
1.7.2.2.1 D Digital
1.7.2.2.2 D Digital Breast Tomosynthesis
1.7.2.2.3 Contrast-Enhanced
1.7.2.2.4 Other Imaging Modality
1.7.2.3 Segmentation By End-User
1.7.2.3.1 Hospitals
1.7.2.3.2 Specialty Clinics
1.7.2.3.3 Diagnostic Centers
1.7.2.3.4 Other End-User
1.7.3 UAE
1.7.3.1 Segmentation By Service
1.7.3.1.1 Screening
1.7.3.1.2 Diagnostic
1.7.3.1.3 Interventional
1.7.3.2 Segmentation By Imaging Modality
1.7.3.2.1 D Digital
1.7.3.2.2 D Digital Breast Tomosynthesis
1.7.3.2.3 Contrast-Enhanced
1.7.3.2.4 Other Imaging Modality
1.7.3.3 Segmentation By End-User
1.7.3.3.1 Hospitals
1.7.3.3.2 Specialty Clinics
1.7.3.3.3 Diagnostic Centers
1.7.3.3.4 Other End-User
1.7.4 Saudi Arabia
1.7.4.1 Segmentation By Service
1.7.4.1.1 Screening
1.7.4.1.2 Diagnostic
1.7.4.1.3 Interventional
1.7.4.2 Segmentation By Imaging Modality
1.7.4.2.1 D Digital
1.7.4.2.2 D Digital Breast Tomosynthesis
1.7.4.2.3 Contrast-Enhanced
1.7.4.2.4 Other Imaging Modality
1.7.4.3 Segmentation By End-User
1.7.4.3.1 Hospitals
1.7.4.3.2 Specialty Clinics
1.7.4.3.3 Diagnostic Centers
1.7.4.3.4 Other End-User
1.7.5 South Africa
1.7.5.1 Segmentation By Service
1.7.5.1.1 Screening
1.7.5.1.2 Diagnostic
1.7.5.1.3 Interventional
1.7.5.2 Segmentation By Imaging Modality
1.7.5.2.1 D Digital
1.7.5.2.2 D Digital Breast Tomosynthesis
1.7.5.2.3 Contrast-Enhanced
1.7.5.2.4 Other Imaging Modality
1.7.5.3 Segmentation By End-User
1.7.5.3.1 Hospitals
1.7.5.3.2 Specialty Clinics
1.7.5.3.3 Diagnostic Centers
1.7.5.3.4 Other End-User
1.7.6 Nigeria
1.7.6.1 Segmentation By Service
1.7.6.1.1 Screening
1.7.6.1.2 Diagnostic
1.7.6.1.3 Interventional
1.7.6.2 Segmentation By Imaging Modality
1.7.6.2.1 D Digital
1.7.6.2.2 D Digital Breast Tomosynthesis
1.7.6.2.3 Contrast-Enhanced
1.7.6.2.4 Other Imaging Modality
1.7.6.3 Segmentation By End-User
1.7.6.3.1 Hospitals
1.7.6.3.2 Specialty Clinics
1.7.6.3.3 Diagnostic Centers
1.7.6.3.4 Other End-User
1.7.7 Rest of LAMEA
1.7.7.1 Segmentation By Service
1.7.7.1.1 Screening
1.7.7.1.2 Diagnostic
1.7.7.1.3 Interventional
1.7.7.2 Segmentation By Imaging Modality
1.7.7.2.1 D Digital
1.7.7.2.2 D Digital Breast Tomosynthesis
1.7.7.2.3 Contrast-Enhanced
1.7.7.2.4 Other Imaging Modality
1.7.7.3 Segmentation By End-User
1.7.7.3.1 Hospitals
1.7.7.3.2 Specialty Clinics
1.7.7.3.3 Diagnostic Centers
1.7.7.3.4 Other End-User
Chapter 2. Company Snapshots
2.1 Hologic, Inc.
2.1.1 Business Overview
2.1.2 Key Information
2.1.3 Company Focus on Mammography Market
2.1.4 Strategic Insights
2.1.5 Strategy Deployed
2.1.6 Product & Service Portfolio
2.1.7 Capability Overview
2.1.8 Core Competencies
2.1.9 Technology & Innovation Focus
2.1.10 SWOT Analysis
2.1.11 Customers / End Users
2.1.12 Competitive Positioning
2.1.13 Key Differentiators
2.1.14 Mammography Portfolio Matrix
2.1.15 Analyst View
2.1.16 Future Outlook
2.2 GE HealthCare Technologies Inc.
2.2.1 Business Overview
2.2.2 Key Information
2.2.3 Company Focus on Mammography Market
2.2.4 Strategic Insights
2.2.5 Strategy Deployed
2.2.6 Product & Service Portfolio
2.2.7 Capability Overview
2.2.8 Technology & Innovation Focus
2.2.9 SWOT Analysis
2.2.10 Customers / End Users
2.2.11 Competitive Positioning
2.2.12 Key Differentiators
2.2.13 Mammography Portfolio Matrix
2.2.14 Analyst View
2.2.15 Future Outlook
2.3 Siemens Healthineers AG
2.3.1 Business Overview
2.3.2 Key Information
2.3.3 Company Focus on Mammography Market
2.3.4 Strategic Insights
2.3.5 Strategy Deployed
2.3.6 Product & Service Portfolio
2.3.7 Capability Overview
2.3.8 Core Competencies
2.3.9 Technology & Innovation Focus
2.3.10 SWOT Analysis
2.3.11 Customers / End Users
2.3.12 Competitive Positioning
2.3.13 Key Differentiators
2.3.14 Mammography Portfolio Matrix
2.3.15 Analyst View
2.3.16 Future Outlook
2.4 FUJIFILM Holdings Corporation
2.4.1 Business Overview
2.4.2 Key Information
2.4.3 Company Focus on Mammography Market
2.4.4 Strategic Insights
2.4.5 Strategy Deployed
2.4.6 Product & Service Portfolio
2.4.7 Capability Overview
2.4.8 Core Competencies
2.4.9 Technology & Innovation Focus
2.4.10 SWOT Analysis
2.4.11 Customers / End Users
2.4.12 Competitive Positioning
2.4.13 Key Differentiators
2.4.14 Mammography Portfolio Matrix
2.4.15 Analyst View
2.4.16 Future Outlook
2.5 Planmed Oy
2.5.1 Business Overview
2.5.2 Key Information
2.5.3 Company Focus on Mammography Market
2.5.4 Strategic Insights
2.5.5 Strategy Deployed
2.5.6 Product & Service Portfolio
2.5.7 Capability Overview
2.5.8 Core Competencies
2.5.9 Technology & Innovation Focus
2.5.10 SWOT Analysis
2.5.11 Customers / End Users
2.5.12 Competitive Positioning
2.5.13 Key Differentiators
2.5.14 Mammography Portfolio Matrix
2.5.15 Analyst View
2.5.16 Future Outlook
2.6 IMS Giotto S.p.A.
2.6.1 Business Overview
2.6.2 Key Information
2.6.3 Company Focus on Mammography Market
2.6.4 Strategic Insights
2.6.5 Strategy Deployed
2.6.6 Product & Service Portfolio
2.6.7 Capability Overview
2.6.8 Technology & Innovation Focus
2.6.9 SWOT Analysis
2.6.10 Customers / End Users
2.6.11 Competitive Positioning
2.6.12 Key Differentiators
2.6.13 Portfolio Matrix
2.6.14 Analyst View
2.6.15 Future Outlook
2.7 Metaltronica S.p.A.
2.7.1 Business Overview
2.7.2 Key Information
2.7.3 Company Focus on Mammography Market
2.7.4 Strategic Insights on Mammography Market
2.7.5 Strategy Deployed
2.7.6 Product & Service Portfolio
2.7.7 Capability Overview
2.7.8 Technology & Innovation Focus
2.7.9 SWOT Analysis
2.7.10 Customers / End Users
2.7.11 Competitive Positioning
2.7.12 Key Differentiators
2.7.13 Portfolio Matrix
2.7.14 Analyst View
2.7.15 Future Outlook
2.8 Trivitron Healthcare Pvt. Ltd.
2.8.1 Business Overview
2.8.2 Key Information
2.8.3 Company Focus on Mammography Market
2.8.4 Strategic Insights
2.8.5 Strategy Deployed
2.8.6 Product & Service Portfolio
2.8.7 Capability Overview
2.8.8 Technology & Innovation Focus
2.8.9 SWOT Analysis
2.8.10 Customers / End Users
2.8.11 Competitive Positioning
2.8.12 Key Differentiators
2.8.13 Portfolio Matrix
2.8.14 Analyst View
2.8.15 Future Outlook
2.9 Allengers Medical Systems Ltd.
2.9.1 Business Overview
2.9.2 Key Information
2.9.3 Company Focus on Mammography Market
2.9.4 Strategic Insights
2.9.5 Strategy Deployed
2.9.6 Product & Service Portfolio
2.9.7 Capability Overview
2.9.8 Technology & Innovation Focus
2.9.9 SWOT Analysis
2.9.10 Customers / End Users
2.9.11 Competitive Positioning
2.9.12 Key Differentiators
2.9.13 Portfolio Matrix
2.9.14 Analyst View
2.9.15 Future Outlook
2.10 MEDI-FUTURE Co., Ltd.
2.10.1 Business Overview
2.10.2 Key Information
2.10.3 Company Focus on Mammography Market
2.10.4 Strategic Insights
2.10.5 Strategy Deployed
2.10.6 Product & Service Portfolio
2.10.7 Capability Overview
2.10.8 Technology & Innovation Focus
2.10.9 SWOT Analysis
2.10.10 Customers / End Users
2.10.11 Competitive Positioning
2.10.12 Key Differentiators
2.10.13 Portfolio Matrix
2.10.14 Analyst View
2.10.15 Future Outlook
Unique Offerings 
